What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Cancer
Douglas C. Bauer mainly investigates Internal medicine, Osteoporosis, Surgery, Bone density and Prospective cohort study.
His Internal medicine course of study focuses on Endocrinology and Parathyroid hormone.
Douglas C. Bauer has researched Osteoporosis in several fields, including Physical therapy and Bone remodeling.
His research integrates issues of Odds ratio, Alendronic acid, Lower risk, Adverse effect and Placebo in his study of Surgery.
His work investigates the relationship between Alendronic acid and topics such as Randomized controlled trial that intersect with problems in Discontinuation.
Douglas C. Bauer combines subjects such as Cross-sectional study, Subclinical infection and Women's Health Initiative with his study of Prospective cohort study.
His most cited work include:
- Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures (3290 citations)
- Primer on the metabolic bone diseases and disorders of mineral metabolism (1854 citations)
- Effects of Continuing or Stopping Alendronate After 5 Years of Treatment The Fracture Intervention Trial Long-term Extension (FLEX): A Randomized Trial (1083 citations)
What are the main themes of his work throughout his whole career to date?
Douglas C. Bauer spends much of his time researching Internal medicine, Osteoporosis, Endocrinology, Prospective cohort study and Surgery.
In most of his Osteoporosis studies, his work intersects topics such as Physical therapy.
His Thyroid function tests, Estrogen and Vitamin D and neurology study in the realm of Endocrinology interacts with subjects such as Context.
His Prospective cohort study research incorporates elements of Incidence, Cohort study, Epidemiology, Gynecology and Pediatrics.
His studies in Surgery integrate themes in fields like Odds ratio, Relative risk, Placebo and Risk factor.
His work deals with themes such as Alendronic acid and Urology, which intersect with Placebo.
He most often published in these fields:
- Internal medicine (54.87%)
- Osteoporosis (33.33%)
- Endocrinology (22.57%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (54.87%)
- Osteoporosis (33.33%)
- Bone mineral (16.98%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Osteoporosis, Bone mineral, Subclinical infection and Randomized controlled trial.
His Internal medicine study combines topics in areas such as Gastroenterology and Endocrinology.
His Osteoporosis research is multidisciplinary, incorporating elements of Orthopedic surgery and Physical therapy.
His Bone mineral study incorporates themes from Oncology, Reduction, Dentistry and Femoral neck.
His work carried out in the field of Subclinical infection brings together such families of science as Meta-analysis, Thyroid disease, Thyroid and Cardiology.
His Randomized controlled trial research is multidisciplinary, incorporating perspectives in Placebo, Quality of life and Clinical trial.
Between 2016 and 2021, his most popular works were:
- Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. (179 citations)
- Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial (111 citations)
- Association of Thyroid Hormone Therapy With Quality of Life and Thyroid-Related Symptoms in Patients With Subclinical Hypothyroidism: A Systematic Review and Meta-analysis. (73 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Cancer
Douglas C. Bauer mostly deals with Internal medicine, Osteoporosis, Placebo, Subclinical infection and Randomized controlled trial.
The study incorporates disciplines such as Endocrinology and Physiology in addition to Internal medicine.
Douglas C. Bauer interconnects Surgery, N-terminal telopeptide and Bone remodeling in the investigation of issues within Osteoporosis.
The various areas that Douglas C. Bauer examines in his Placebo study include Relative risk, Quality of life and Urology.
The Randomized controlled trial study combines topics in areas such as Levothyroxine, Physical therapy, Gastroenterology and Body mass index.
Douglas C. Bauer has included themes like Bone mineral, Bone density and Surrogate endpoint in his Femoral neck study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
